Financials data is unavailable for this security.
Cash flow in CADView more
In 2021, cash reserves at Khiron Life Sciences Corp fell by 12.73m. Cash Flow from Financing totalled 10.90m or 85.15% of revenues. In addition the company used 20.40m for operations while cash used for investing totalled 2.09m.
Cash flow per share | -0.1466 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.1248 |
---|---|
Tangible book value per share | 0.0927 |
More ▼
Balance sheet in CADView more
Current ratio | 1.91 |
---|---|
Quick ratio | 0.9133 |
Total debt/total equity | 0.0946 |
---|---|
Total debt/total capital | 0.0864 |
More ▼